Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Kumar, Nathella Pavan ^a,b   Banurekha, Vaithilingam V ^b   Nair, Dina ^b   Sridhar, Rathinam ^c   Kornfeld, Hardy ^d   Nutman, Thomas B ^e   Babu, Subash ^a,e  

^a National Institutes of Health International Center for Excellence in Research   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c Government Stanley Hospital   (India)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BETA INTERFERON; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; BACTERIAL COUNT; COMORBIDITY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNE DYSREGULATION; IMPAIRED GLUCOSE TOLERANCE; INNATE IMMUNITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ADOLESCENT; BLOOD; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84911478403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112108     Document Type: Article

References (33)

1. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M (2013) Prediabetes: a high-risk state for diabetes development. Lancet 379: 2279-2290.
2. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
3. Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diab Rep 9: 193-199.
4. Forouhi NG, Luan J, Hennings S, Wareham NJ (2007) Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med 24: 200-207.
5. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, et al. (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30: 753-759.
6. Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Fay MP, et al. (2013) Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines. Ann Am Thorac Soc 10: 441-449.
7. Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, et al. (2008) Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis 47: 634-641.
8. Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, et al. (2012) Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 7: e41367.
9. Wang Q, Ma A, Han X, Zhao S, Cai J, et al. (2013) Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study. PLoS One 8: e82660.
10. Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9: 737-746.
11. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, et al. (2003) The Chennai Urban Rural Epidemiology Study (CURES) -study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51: 863-870.
12. Harries AD, Lin Y, Satyanarayana S, Lonnroth K, Li L, et al. (2011) The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 15: 1436-1444.
13. Kapur A, Harries AD (2013) The double burden of diabetes and tuberculosis - Public health implications. Diabetes Res Clin Pract.
14. Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, et al. (2013) Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 13: 436-448.
15. Sullivan T, Ben Amor Y (2012) The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med 9: e1001269.
16. Velloso LA, Eizirik DL, Cnop M (2013) Type 2 diabetes mellitus-an autoimmune disease? Nat Rev Endocrinol 9: 750-755.
17. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98-107.
18. McNelis JC, Olefsky JM (2014) Macrophages, Immunity, and Metabolic Disease. Immunity 41: 36-48.
19. Martinez N, Kornfeld H (2014) Diabetes and immunity to tuberculosis. Eur J Immunol 44: 617-626.
20. Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93 Suppl: S10-14.
21. Restrepo BI, Schlesinger LS (2014) Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract.
22. Cooper AM, Mayer-Barber KD, Sher A (2011) A Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4: 252-260.
23. Torrado E, Cooper AM (2013) Cytokines in the balance of protection and pathology during mycobacterial infections. Adv Exp Med Biol 783: 121-140.
24. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527.
25. Dorhoi A, Kaufmann SH (2014) Tumor necrosis factor alpha in mycobacterial infection. Semin Immunol 26: 203-209.
26. Torrado E, Robinson RT, Cooper AM (2011) Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 32: 66-72.
27. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
28. Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, et al. (2011) Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35: 1023-1034.
29. Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, et al. (2014) Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511: 99-103.
30. Kumar NP, Sridhar R, Banurekha VV, Jawahar MS, Nutman TB, et al. (2013) Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis 208: 739-748.
31. Ellner JJ (2010) Immunoregulation in TB: observations and implications. Clin Transl Sci 3: 23-28.
32. Rook GA (2007) Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 7: 327-337.
33. Kumar NP, George PJ, Kumaran P, Dolla CK, Nutman TB, et al. (2014) Diminished Systemic and Antigen-Specific Type 1, Type 17, and Other Proinflammatory Cytokines in Diabetic and Prediabetic Individuals With Latent Mycobacterium tuberculosis Infection. J Infect Dis.